about
Gastric biomarkers: a global reviewIndividualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresSecond-line treatment of metastatic gastric cancer: Current options and future directionsAlterations of the TP53 gene in gastric and esophageal carcinogenesisLong non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translationLow ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines.Molecular mechanisms of chemoresistance in gastric cancerInterrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma.Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancerStudy on detection of mutation DNA fragment in gastric cancer by restriction endonuclease fingerprinting with capillary electrophoresis.The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients.Pathogenetic mechanisms in gastric cancer.High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study.Discrimination of p53 immunohistochemistry-positive tumors by its staining pattern in gastric cancerA compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines.Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome.Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma.Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas.Analysis of p53, K-ras gene mutation & Helicobacter pylori infection in patients with gastric cancer & peptic ulcer disease at a tertiary care hospital in north IndiaHypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomasp53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions.Nitric oxide and cancer: a review.PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression.p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cellsClinical Relevance and Molecular Phenotypes in Gastric Cancer, of TP53 Mutations and Gene Expressions, in Combination With Other Gene Mutations.Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.Eradication of Helicobacter pylori Infection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium.Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer.The expression and clinical significance of miR-132 in gastric cancer patients.Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Molecular pathology of gastric carcinoma.Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers.Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.Targeting deficient DNA damage repair in gastric cancer.Prognostic significance of KLF4 expression in gastric cancer.Prognostic significance of USP10 as a tumor-associated marker in gastric carcinoma.
P2860
Q26741859-EECCAC94-36E3-4DC7-9EF3-BC3208E63034Q26776198-D96B9927-E2E0-4636-83FC-61DDF2894103Q26778027-4C403B29-3F25-4BB4-AA9B-9A57BA543194Q26866191-180B286A-7632-4F2F-9798-FC79777C4E80Q26996377-8FF250AC-AF70-4F55-8BDC-F94461479689Q27853007-8AA354D5-069F-4A9C-BA7D-35B8949AE811Q28069259-65E7EBF0-A930-42C2-9F92-E8A8E96A5254Q33484376-B02A5E42-3DA7-467C-A9E4-54378F616722Q33919232-A4E05786-3F61-492D-A35B-492024855D3EQ33964097-96EC423A-5310-4893-A1FF-EB1470BFFBD1Q34117864-88589084-546A-44FA-936F-0CBD2D710D27Q34326627-37588576-4EE9-4A1E-B283-42C5CAF7CCC3Q34396531-E0B6F366-43BC-4C18-8C01-E2E019ED0888Q35032319-F0E6232A-8AFC-4A81-8D89-E9B94C897C42Q35108769-3BF253A4-6A8B-44BA-9356-B119C80320CAQ35562690-68136E3F-A151-4CFC-9D1B-577788E50DB4Q35677250-26176317-C26B-4491-A577-58D4E04120C1Q36136842-2C91A0A0-7083-481B-9D48-CC76BDBF926BQ36148016-88147476-56C6-4F30-BA2E-E1F838852124Q36234652-F1D51DA2-42F8-4645-9E23-48EA07CF1096Q36450006-993B22B5-E6B3-491C-BE7B-FE6C41E38704Q36610552-9C895010-C965-4D9A-8D25-6AD0B985FC6FQ36673635-0C2FF9C5-ED60-4F61-89AA-A98F773B1B9BQ36764924-D4D1A9B4-C44C-426A-89AE-47D9C2CF53B7Q36861610-F80B7D3C-338F-4BEF-AC2D-0961904F5160Q36893209-A7E567FC-E478-4685-B6B8-23B290E672EDQ37235547-F20E35E3-18A4-45AE-B859-2F5DE7CAD009Q37297983-1B36E0EF-D3D8-469E-8660-79A06928F4A0Q37314818-660A6B2B-34A2-48F2-B301-46D73894B6F0Q37370299-3057F6BE-85FE-45EF-A34D-6ECED9401743Q37426250-8CA5E1BC-CF90-47D2-BD59-84D1A5B0BE1EQ37520516-F90E1333-2636-4CFE-ACE0-A1DE757731CBQ37683714-03EF33B1-1CE2-4881-AFA2-24E62C3634DAQ37824622-01B96304-0B92-4631-B900-83114E68EF25Q37959106-8B198143-BC09-4A7C-8891-8CB5DE966B50Q38687568-6D29CD16-07BF-45BD-916B-EC3322A543C3Q38728416-3A91D50E-B22A-48EE-996D-75783758467FQ38834760-43652499-F28B-45F4-815D-0DFB843D48FFQ38868138-ED7674EF-ACEE-4777-ADC3-78E72D3089CCQ39042827-01C5C322-56A9-4BD4-A93C-64B3DC144DE4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
TP53 and gastric carcinoma: a review.
@ast
TP53 and gastric carcinoma: a review.
@en
type
label
TP53 and gastric carcinoma: a review.
@ast
TP53 and gastric carcinoma: a review.
@en
prefLabel
TP53 and gastric carcinoma: a review.
@ast
TP53 and gastric carcinoma: a review.
@en
P2093
P356
P1433
P1476
TP53 and gastric carcinoma: a review.
@en
P2093
Fenoglio-Preiser CM
Noffsinger A
Stemmermann GN
P304
P356
10.1002/HUMU.10180
P577
2003-03-01T00:00:00Z